General Information of the Compound
Compound ID
CP0137005
Compound Name
US10501467, Example 31
    Show/Hide
Synonyms
Dihydrodiazepinocarbazolone derivative 1
PMID27841036-Compound-26
    Show/Hide
Structure
Formula
C22H28N4O
Molecular Weight
364.493
Canonical SMILES
CC1(C)Cc2n(CCN3CCCCC3)c3cccc4c3c2c(C1)n[nH]c4=O
    Show/Hide
InChI
InChI=1S/C22H28N4O/c1-22(2)13-16-20-18(14-22)26(12-11-25-9-4-3-5-10-25)17-8-6-7-15(19(17)20)21(27)24-23-16/h6-8H,3-5,9-14H2,1-2H3,(H,24,27)
    Show/Hide
InChIKey
LNWPRZVIPZXIHL-UHFFFAOYSA-N
Physicochemical Property
logP
3.5471
Rotatable Bonds
3
Heavy Atom Count
27
Polar Areas
49.63
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
4
Complexity
27

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 71626523
ChEMBL ID
CHEMBL3984980
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00839, Poly [ADP-ribose] polymerase 1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000017 HeLa Homo sapiens (Human)  1
1
EC50 = 3.2 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 IC50 = 2.9 nM
Clinical Information about the Compound
Drug 1 ( Dihydrodiazepinocarbazolone derivative 1 )
Drug Name Dihydrodiazepinocarbazolone derivative 1
Company BeiGene Ltd
Target(s)
Poly [ADP-ribose] polymerase 1 (PARP1)
Inhibitor
Poly [ADP-ribose] polymerase 2 (PARP2)
Inhibitor